There is no cure for type 1 diabetes and many find it challenging to manage this condition. Scientists have come up with a new technology to help better control your type 1diabetes.
Statistics show an alarmingly increased rate of this disease, especially in children.
Type 1 diabetes can fundamentally affect an individual's life, as individuals need to screen their glucose levels consistently to guarantee they are not dangerously high or low.
Individuals with type 1 diabetes measure their glucose levels by pricking a finger a few times each day or wearing a glucose screen. Contingent upon the estimations, they may need to direct insulin utilizing an infusion or insulin pump.
But now scientists are trying a new technology that could replace the traditional methods.
Automatic Insulin System
They targeted a particular kind of artificial pancreas, a closed circle control. These gadgets consistently screen and regulate blood glucose levels. At the point when the screen identifies that an individual needs insulin, a pump discharges the hormone into the body. This trial included the utilization of the Control-IQ system, another kind of fake pancreas that utilizes calculations to modify insulin dosages consequently for the duration of the day.
Specialists needed to replicate everyday life, so they didn't screen the system remotely. Members however contacted researchers at regular intervals to check information from the gadget.
By simplifying the type 1 diabetes management, this innovation could diminish the every day burden of this condition, while likewise conceivably lessening diabetes complications, such as eye and kidney diseases.
Relieving the Burden
The specialists wanted to measure the time that blood glucose levels reached the targeted 70 to 180 milligrams for each deciliter.
The outcomes indicated that the glucose levels of the individuals who utilized the Control-IQ system were in the objective range for about 2.6 hours per day longer than before.
Fundamentally, the system likewise improved the blood glucose control at night just as during the day. This is an essential progression for individuals whose levels drop altogether when sleeping.
More importantly none of the members experienced extreme hypoglycemia when glucose levels become low.
According to researchers these discoveries show that this innovative system can possibly improve the overall health of individuals living with type 1 diabetes, while likewise posibly relieving the burden from those with the disease and their guardians.
The device was just approved for use by the Food and Drug Administration. It will reach patients in January 2020.
